XML 36 R26.htm IDEA: XBRL DOCUMENT v3.10.0.1
Derivative Instruments (Tables)
9 Months Ended
Dec. 31, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments
As of December 31, 2018, the Company had the following derivative contracts recorded at fair value:
 
Designated Derivative Contracts
 
Non-Designated Derivative Contracts
 
Total
Notional value
$
19,156

 
$
7,894

 
$
27,050

Fair value recorded in other current assets
1,850

 
94

 
1,944

Fair value recorded in other accrued expenses

 
(5
)
 
(5
)


Schedule of location and amount of gains and losses related to derivatives designated as hedging instruments reported in consolidated financial statements
The following table summarizes the effect of Designated Derivative Contracts:
 
Three Months Ended December 31,
 
Nine Months Ended December 31,
 
2018
 
2017
 
2018
 
2017
Amount of gain (loss) on derivative instruments (effective portion) recognized in other comprehensive (loss) income
$
998

 
$
108

 
$
8,356

 
$
(9,682
)
Amount of gain (loss) reclassified from accumulated other comprehensive (loss) income into net sales (effective portion)
5,127

 
(3,914
)
 
7,293

 
(6,197
)
Amount of gain excluded from effectiveness testing recognized in SG&A expenses
363

 
273

 
1,843

 
1,045


Schedule of location and amount of gains and losses related to derivatives not designated as hedging instruments reported in consolidated financial statements
The following table summarizes the effect of Non-Designated Derivative Contracts:
 
Three Months Ended December 31,
 
Nine Months Ended December 31,
 
2018
 
2017
 
2018
 
2017
Amount of gain (loss) on derivative instruments recognized in SG&A expenses
$
504

 
$
211

 
$
1,241

 
$
(2,455
)